Literature DB >> 1964081

Malignant rhabdoid tumor: a highly malignant childhood tumor with minimal karyotypic changes.

E C Douglass1, M Valentine, S T Rowe, D M Parham, J A Wilimas, J M Sanders, P J Houghton.   

Abstract

Malignant rhabdoid tumors (MRT) are rare; thus very few cytogenetic studies of this type of tumor have been performed. We report the results of cytogenetic studies of 10 MRTs from various anatomic primary sites. Six cases had normal diploid karyotypes with no detectable rearrangements or aneuploidy except for occasional tetraploid cells. In 4 of these cases the tumor phenotype was verified by electron microscopic studies. In a seventh case only normal cells were identified in short-term culture, but a del(13)(q14) appeared after 4 months in culture. A soft tissue MRT contained a translocation, t(8;15)(q12;p11), and a liver MRT contained a del(3)(q21) or t(3;?)(q21;?). The single case of a primary brain MRT had monosomy 22 with deletion of part of the remaining chromosome 22. Our findings indicate that visible chromosomal rearrangements occur in fewer than half of MRTs. When combined with other reported series, our study indicates that monosomy 22 is a non-random chromosomal abnormality in primary MRT of the brain.

Entities:  

Mesh:

Year:  1990        PMID: 1964081     DOI: 10.1002/gcc.2870020308

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  14 in total

Review 1.  A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature.

Authors:  Mariela C Coccé; Fabiana Lubieniecki; Uwe Kordes; Daniel Alderete; Marta S Gallego
Journal:  J Neurooncol       Date:  2010-12-03       Impact factor: 4.130

Review 2.  Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system.

Authors:  R P Hasserjian; R D Folkerth; R M Scott; D E Schofield
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 3.  Malignant rhabdoid tumor of the colon: report of a case.

Authors:  I Nakamura; K Nakano; K Nakayama; Y Ishii; K Ohta; M Takahashi; T Yamada; K Yamaguchi; H Sakuma; A Tsuchiya; S Takenoshita
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.

Authors:  N Sévenet; E Sheridan; D Amram; P Schneider; R Handgretinger; O Delattre
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

5.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood.

Authors:  L B Rorke; R Packer; J Biegel
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 6.  Malignant rhabdoid tumour of the oesophagus: a case report.

Authors:  W C Ng; H T Leong; K F Ma; W L Yip; W M Suen
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

7.  The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney.

Authors:  A J Garvin; G G Re; B I Tarnowski; D J Hazen-Martin; D A Sens
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.

Authors:  Elizabeth S McKenna; Courtney G Sansam; Yoon-Jae Cho; Heidi Greulich; Julia A Evans; Christopher S Thom; Lisa A Moreau; Jaclyn A Biegel; Scott L Pomeroy; Charles W M Roberts
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

Review 9.  Case-based review: atypical teratoid/rhabdoid tumor.

Authors:  Cody L Nesvick; Amulya A Nageswara Rao; Aditya Raghunathan; Jaclyn A Biegel; David J Daniels
Journal:  Neurooncol Pract       Date:  2018-10-05

10.  hSNF5 /INI1 mutation analysis in acute myeloid leukemia.

Authors:  Yu-Chieh Su; Chao-Bin Chen; Ya-Ting Chang; Ya-Ting Tung; Dian-Kun Li
Journal:  Int J Hematol       Date:  2008-02-13       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.